TAS2R30
Taste receptor type 2 member 30
Also known as: T2R30, T2R30_HUMAN, TAS2R47
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59541
- Gene
- TAS2R30
- Ensembl
- ENSG00000256188
- Chromosome
- 12
- Canonical length
- 319 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Enables bitter taste receptor activity. Involved in detection of chemical stimulus involved in sensory perception of bitter taste. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
319 residues, UniProt reviewed canonical sequence.
>P59541|TAS2R30
1 MITFLPIIFS ILIVVIFVIG NFANGFIALV NSIEWVKRQK ISFVDQILTA LAVSRVGLLW
61 VLLLHWYATQ LNPAFYSVEV RITAYNVWAV TNHFSSWLAT SLSMFYLLRI ANFSNLIFLR
121 IKRRVKSVVL VILLGPLLFL VCHLFVINMD ETVWTKEYEG NVTWKIKLRS AMYHSNMTLT
181 MLANFVPLTL TLISFLLLIC SLCKHLKKMQ LHGKGSQDPS TKVHIKALQT VTSFLLLCAI
241 YFLSMIISVC NFGRLEKQPV FMFCQAIIFS YPSTHPFILI LGNKKLKQIF LSVLRHVRYW
301 VKDRSLRLHR FTRGALCVFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAS2R30 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- retina: 0.2 nTPM
- bone marrow: 0.1 nTPM
- breast: 0.1 nTPM
- cerebellum: 0.1 nTPM
- endometrium: 0.1 nTPM
- ovary: 0.1 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- astrocytes: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 10 nTPM
- white matter: 7.8 nTPM
- hypothalamus: 7.6 nTPM
- cerebral cortex: 6.5 nTPM
- pons: 6.4 nTPM
- thalamus: 6.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -2.07
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAS2R30 as an antibody target. Whether an autoantibody or antibody against TAS2R30 could matter depends on whether native TAS2R30 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAS2R30 is annotated at the cell surface, where native TAS2R30 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TAS2R30 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...